OHR PHARMACEUTICAL INC's ticker is and the CUSIP is 67778H900. A total of 4 filers reported holding OHR PHARMACEUTICAL INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $4,000 | -20.0% | 20,500 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | -94.0% | 20,500 | -54.3% | 0.00% | -100.0% |
Q4 2017 | $84,000 | +2700.0% | 44,900 | +1022.5% | 0.00% | – |
Q2 2017 | $3,000 | -25.0% | 4,000 | -20.0% | 0.00% | – |
Q1 2017 | $4,000 | -86.2% | 5,000 | -74.4% | 0.00% | – |
Q4 2016 | $29,000 | -49.1% | 19,500 | -3.5% | 0.00% | -100.0% |
Q3 2016 | $57,000 | -56.8% | 20,200 | -58.1% | 0.00% | -50.0% |
Q2 2016 | $132,000 | -27.1% | 48,200 | -14.5% | 0.00% | -33.3% |
Q1 2016 | $181,000 | -90.1% | 56,400 | -81.1% | 0.00% | -86.4% |
Q4 2015 | $1,828,000 | +6670.4% | 297,700 | +2907.1% | 0.02% | – |
Q3 2015 | $27,000 | -3.6% | 9,900 | -11.6% | 0.00% | – |
Q2 2015 | $28,000 | -80.0% | 11,200 | -79.7% | 0.00% | -100.0% |
Q1 2015 | $140,000 | -61.6% | 55,200 | +26.0% | 0.00% | -66.7% |
Q4 2014 | $365,000 | +43.7% | 43,800 | +25.1% | 0.01% | +50.0% |
Q3 2014 | $254,000 | -89.9% | 35,000 | -86.8% | 0.00% | -89.7% |
Q2 2014 | $2,515,000 | +8572.4% | 264,500 | +12495.2% | 0.04% | – |
Q1 2014 | $29,000 | – | 2,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Platinum Management (NY) LLC | 16 | $3,000 | 0.00% |
GROUP ONE TRADING, L.P. | 2,100 | $29,000 | 0.00% |